Total Payments
$28,437
2024 Payments
$4,999
Companies
38
Transactions
766
Medicare Patients
7,614
Medicare Billing
$600,271
Payment Breakdown by Category
Food & Beverage$22,116 (77.8%)
Consulting$5,070 (17.8%)
Travel$1,209 (4.3%)
Education$42.35 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,116 | 755 | 77.8% |
| Consulting Fee | $5,070 | 1 | 17.8% |
| Travel and Lodging | $1,209 | 7 | 4.3% |
| Education | $42.35 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $7,670 | 35 | $0 (2024) |
| ABBVIE INC. | $3,925 | 148 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,260 | 76 | $0 (2024) |
| Lilly USA, LLC | $1,828 | 51 | $0 (2024) |
| GENZYME CORPORATION | $1,666 | 38 | $0 (2024) |
| Amgen Inc. | $1,598 | 81 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,111 | 52 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $890.09 | 25 | $0 (2024) |
| Incyte Corporation | $700.29 | 14 | $0 (2024) |
| MAYNE PHARMA INC. | $692.79 | 43 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,999 | 125 | GENZYME CORPORATION ($855.92) |
| 2023 | $10,662 | 138 | E.R. Squibb & Sons, L.L.C. ($6,806) |
| 2022 | $3,410 | 127 | ABBVIE INC. ($954.77) |
| 2021 | $1,965 | 96 | AbbVie Inc. ($602.36) |
| 2020 | $1,120 | 59 | Amgen Inc. ($296.12) |
| 2019 | $3,039 | 112 | AbbVie, Inc. ($684.57) |
| 2018 | $1,256 | 60 | AbbVie, Inc. ($259.17) |
| 2017 | $1,985 | 49 | AbbVie, Inc. ($466.89) |
All Payment Transactions
766 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $4.19 | General |
| 12/18/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.31 | General |
| Category: Immunology | ||||||
| 12/05/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: Dermatology | ||||||
| 11/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $162.30 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.81 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.62 | General |
| Category: Immunology | ||||||
| 11/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $111.58 | General |
| 11/12/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: Dermatology | ||||||
| 11/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $119.79 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $138.24 | General |
| Category: Immunology | ||||||
| 10/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.29 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $11.27 | General |
| 10/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,058 | 3,685 | $836,278 | $167,900 |
| 2022 | 21 | 1,935 | 3,517 | $805,435 | $157,579 |
| 2021 | 23 | 2,273 | 3,823 | $883,340 | $181,814 |
| 2020 | 15 | 1,348 | 2,214 | $360,500 | $92,977 |
Total Patients
7,614
Total Services
13,239
Medicare Billing
$600,271
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 307 | 445 | $186,900 | $39,918 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 354 | 454 | $134,838 | $28,093 | 20.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 363 | 518 | $115,514 | $20,305 | 17.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 232 | 254 | $85,852 | $17,268 | 20.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 62 | 73 | $73,803 | $16,860 | 22.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 160 | 182 | $68,796 | $14,097 | 20.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 276 | 1,394 | $32,062 | $7,225 | 22.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $29,538 | $5,822 | 19.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 58 | 82 | $13,776 | $3,341 | 24.3% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 26 | 29 | $23,577 | $2,868 | 12.2% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 24 | 26 | $24,102 | $2,859 | 11.9% |
| 10040 | Acne surgery | Office | 2023 | 26 | 29 | $11,223 | $2,622 | 23.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 36 | 36 | $13,284 | $2,270 | 17.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 18 | 19 | $10,678 | $2,185 | 20.5% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 17 | 26 | $4,940 | $966.58 | 19.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 16 | $2,976 | $634.76 | 21.3% |
| 69100 | Biopsy of ear | Office | 2023 | 11 | 11 | $3,531 | $537.44 | 15.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 18 | 37 | $888.00 | $28.65 | 3.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 273 | 391 | $162,656 | $32,170 | 19.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 304 | 384 | $113,280 | $23,003 | 20.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 75 | 81 | $81,000 | $18,764 | 23.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 337 | 462 | $102,102 | $17,747 | 17.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 202 | 233 | $78,754 | $15,997 | 20.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 121 | 141 | $52,734 | $11,512 | 21.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 262 | 1,394 | $32,062 | $7,062 | 22.0% |
About Dr. Kathryn Durham, MD
Dr. Kathryn Durham, MD is a Dermatology healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2011. The National Provider Identifier (NPI) number assigned to this provider is 1700171196.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kathryn Durham, MD has received a total of $28,437 in payments from pharmaceutical and medical device companies, with $4,999 received in 2024. These payments were reported across 766 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($22,116).
As a Medicare-enrolled provider, Durham has provided services to 7,614 Medicare beneficiaries, totaling 13,239 services with total Medicare billing of $600,271. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Fort Worth, TX
- Active Since 06/14/2011
- Last Updated 07/06/2017
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700171196
Products in Payments
- Otezla (Drug) $1,838
- DUPIXENT (Biological) $1,506
- COSENTYX (Biological) $1,250
- TALTZ (Drug) $1,192
- RINVOQ (Biological) $1,171
- Humira (Biological) $1,048
- COSENTYX (Drug) $875.64
- SKYRIZI (Biological) $818.59
- OPZELURA (Drug) $700.29
- Sotyktu (Drug) $595.52
- DORYX (Drug) $531.01
- ADBRY (Biological) $448.47
- HUMIRA (Biological) $417.95
- EPIDUO FORTE (Drug) $405.68
- Bimzelx (Biological) $405.52
- Zoryve (Drug) $404.80
- TREMFYA (Drug) $391.39
- OLUMIANT (Drug) $371.88
- VTAMA (Drug) $323.89
- DUPIXENT (Drug) $244.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Fort Worth
Dr. Patrick Keehan, D.o, D.O
Dermatology — Payments: $761,024
Dermatology $761,024
Dr. Ronald Plott, M.d, M.D
Dermatology — Payments: $467,637
Dermatology $467,637
William Cothern, Do, DO
Dermatology — Payments: $41,403
Dermatology $41,403
Stephen Weis, Do, DO
Dermatology — Payments: $32,162
Dermatology $32,162
Mrs. Betty Rajan, M.d, M.D
Dermatology — Payments: $25,857
Dermatology $25,857
Dr. James Mccarty, M.d, M.D
Dermatology — Payments: $20,110
Dermatology $20,110